The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy
Open accessAbstract
Most tumor cells show different metabolic pathways than normal cells. Even under the conditions of sufficient oxygen, they produce energy by a high rate of glycolysis followed by lactic acid fermentation in the cytosol, which is known as aerobic glycolysis or the Warburg effect. Lung cancer is a malignant tumor with one of the highest incidence and mortality rates in the world at present. However, the exact mechanisms underlying lung cancer development remain unclear. The three key enzymes of glycolysis are hexokinase, phosphofructokinase, and pyruvate kinase. Lactate dehydrogenase catalyzes the transfer of pyruvate to lactate. All four enzymes have been reported to be overexpressed in tumors, including lung cancer, and can be regulated by many oncoproteins to promote tumor proliferation, migration, and metastasis with dependence or independence of glycolysis. The discovery of aerobic glycolysis in the 1920s has provided new means and potential therapeutic targets for lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Patra, K. C., Wang, Q., Bhaskar, P. T., Miller, L., Wang, Z., Wheaton, W., Chandel, N., Laakso, M., Muller, W. J., Allen, E. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.014 · Cited by 853
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209603 · Cited by 765
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 659
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
Robey, R. B., & Hay, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209595 · Cited by 536
Xie, H., Hanai, J.-I., Ren, J.-G., Kats, L., Burgess, K., Bhargava, P., Signoretti, S., Billiard, J., Duffy, K. J., Grant, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.003 · Cited by 516
for the ‘Tumour and Angiogenesis Research Group’, Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Bougioukas, G., Didilis, V, Gatter, K. C., & Harris, A. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601205 · Cited by 377
Lehninger Principles of Biochemistry (5th edition)
Nelson, D. L., & Cox, M. M. (2008) · Cited by 348
Lung cancer incidence and mortality in China, 2009
Chen, W., Zheng, R., Zhang, S., Zou, X., Zhao, P., & He, J. (2013) · Thoracic Cancer · doi:10.1111/1759-7714.12025 · Cited by 309
Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
Clem, B. F., O'Neal, J., Tapolsky, G., Clem, A. L., Imbert-Fernandez, Y., Kerr, D. A., Klarer, A. C., Redman, R., Miller, D. M., Trent, J. O., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0097 · Cited by 276
MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene
Fang, R., Xiao, T., Fang, Z., Sun, Y., Li, F., Gao, Y., Feng, Y., Li, L., Wang, Y., Liu, X., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373084 · Cited by 253
Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence
ZWERSCHKE, W., MAZUREK, S., STÖCKL, P., HÜTTER, E., EIGENBRODT, E., & JANSEN-DÜRR, P. (2003) · Biochemical Journal · doi:10.1042/bj20030816 · Cited by 247
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
Telang, S., Yalcin, A., Clem, A. L., Bucala, R., Lane, A. N., Eaton, J. W., & Chesney, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209709 · Cited by 168
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Pan, J. G., & Mak, T. W. (2007) · Science s STKE · doi:10.1126/stke.3812007pe14 · Cited by 147
Koukourakis, M. I., Giatromanolaki, A. N., & Sivridis, E. (2003) · Tumor Biology · doi:10.1159/000074430 · Cited by 121
Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
Mohamed, A., Deng, X., Khuri, F. R., & Owonikoko, T. K. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.09.001 · Cited by 121
Lung cancer incidence and mortality in C hina, 2011
Zheng, R., Zeng, H., Zuo, T., Zhang, S., Qiao, Y., Zhou, Q., & Chen, W. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12286 · Cited by 119
Self-citationOxidative stress‐responsive microRNA‐320 regulates glycolysis in diverse biological systems
Tang, H., Lee, M. C., Sharpe, O., Salamone, L., Noonan, E. J., Hoang, C. D., Levine, S., Robinson, W. H., & Shrager, J. B. (2012) · The FASEB Journal · doi:10.1096/fj.11-197467 · Cited by 113
Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
Guo, W., Zhang, Y., Chen, T., Wang, Y., Xue, J., Zhang, Y., Xiao, W., Mo, X., & Lü, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0860-5 · Cited by 99
Luo, F., Liu, X., Yan, N., Li, S., Cao, G., Cheng, Q., Xia, Q., & Wang, H. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-26 · Cited by 91
Kayser, G., Kassem, A., Sienel, W. G. R., Schulte-Uentrop, L., Mattern, D., Aumann, K., Stickeler, E., Werner, M., Passlick, B., & Hausen, A. Z. (2010) · Diagnostic Pathology · doi:10.1186/1746-1596-5-22 · Cited by 80
Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Parnell, K. M., Foulks, J. M., Nix, R. N., Clifford, A., Bullough, J., LUO, B. H., Senina, A. V., Vollmer, D., Liu, J., McCarthy, V., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0026 · Cited by 76
Katabi, M. M., Chan, H. L. B., Karp, S. E., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950018959 · Cited by 71
Yohena, T., Yoshino, I., Takenaka, T., 亀山, 敏., Ohba, T., Kuniyoshi, Y., & Maehara, Y. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819852d5 · Cited by 60
Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer
Chen, Y., Zhang, H., Xu, A., Li, N., Liu, J., Liu, C., Lv, D.-X., Wu, S., Huang, L., Yang, S., et al. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.06.014 · Cited by 60
Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression
Kayser, G., Sienel, W. G. R., Kubitz, B., Mattern, D., Stickeler, E., Passlick, B., Werner, M., & Hausen, A. Z. (2011) · Pathology · doi:10.1097/pat.0b013e32834c352b · Cited by 60
p53 protects lung cancer cells against metabolic stress
Clair, D. K. S. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000811 · Cited by 57
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family overexpression in human lung tumor.
Minchenko, О. H., Ogura, T., Opentanova, I., Minchenko, D. O., Ochiai, A., Caro, J., Комісаренко, С. В., & Esumi, H. (2005) · PubMed · Cited by 28
Cited by
Feng, J., Yang, H., Zhang, Y., Wei, H., Zhu, Z., Zhu, B., Yang, M., Cao, W., Wang, L., & Wu, Z. (2017) · Oncogene · doi:10.1038/onc.2017.188 · Cited by 415
Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
Tran, D. H., & Wang, Z. V. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012673 · Cited by 335
Emerging roles of aerobic glycolysis in breast cancer
Wu, Z., Wu, J., Zhao, Q., Fu, S., & Jin, J. (2020) · Clinical and Translational Oncology · doi:10.1007/s12094-019-02187-8 · Cited by 255
Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective
Missiaen, R., Morales-Rodriguez, F., Eelen, G., & Carmeliet, P. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.01.001 · Cited by 58
Tubular Cell Glucose Metabolism Shift During Acute and Chronic Injuries
Faivre, A., Verissimo, T., Auwerx, H., Legouis, D., & de Seigneux, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.742072 · Cited by 64
Metadata
- Authors
- Li, X., Gu, J., & Zhou, Q.
- Venue
- Thoracic Cancer
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 6
- Issue
- 1
- Pages
- 17-24
- ISSN
- 1759-7706 (ISSN-L)
- 1759-7714
- OpenAlex
- W1893330971
- Cited by
- 331
- References
- 35
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.